Representative Matters:

  • Representing E-Vapor Industry trade associations in a lawsuit challenging FDA’s Deeming Regulation and aspects of the Tobacco Control Act in the U.S. District Court for the District of Columbia.
  • Defending major e-liquid company and manufacturer in false advertising class action lawsuit in California’s Orange County Superior Court, Complex Division
  • Advised e-liquid companies on EU Tobacco Products Directive and Member State laws and labeling requirements
  • Representing a Coalition of e-vapor companies challenging the constitutionality of Indiana’s new e-liquid law (HEA 1432/SEA 463) in federal district court
  • Advised e-vapor companies on the development of product standards in the U.S., EU, and China
  • Established a Working Group of Chinese e-cigarette stakeholders dedicated to working with the government authorities to develop appropriate, product-specific regulations and standards for e-cigarettes and e-liquids in China
  • Advised e-liquid producer on safety of e-liquid ingredients, including diacetyl and related compounds
  • Advised manufacturers of filter components of the impact of product changes on customer compliance issues
  • Advised paper manufacturers of the impact on compliance obligations arising from changes in processing aids
  • Presented at Tobacco Merchant Association conference on Deeming Regulation issues
  • Presented at FDLI Introduction to Tobacco Law and Regulation Seminar on Product Standards, Menthol, and FDA’s Deeming Regulation
  • Presented at an FDA workshop on risk reduction and the utility of risk assessment techniques for evaluating non-combustion sources of inhaled nicotine
  • Presented at the American Chamber of Commerce in Shanghai, China on the Evolution of FDA and Global Regulation of Electronic Cigarettes
  • Conducted numerous webinars for FDLI and other organizations on tobacco and nicotine product regulation by FDA
  • Acting as General Counsel to trade association of e-liquid companies and 501(c)(3) research foundation
  • Attended with FDA to familiarize staff with the variety of advanced, non-combustion delivery vehicles for vaping nicotine and aromatics (with or without nicotine)
  • Prepared trade association comments to OMB regarding FDA’s efforts to justify its proposed Deeming Regulation with regard to the objectives of the Paperwork Reduction Act
  • Prepared comments to FDA proposals regarding Modified Risk Tobacco Product Applications, Harmful and Potentially Harmful Constituent disclosure requirements, regulation of menthol, and the Deeming Regulation
  • Attended meetings at FDA’s Center for Tobacco Products on behalf of clients
  • Advised clients regarding compliance with California law to e-liquid company
  • Authored numerous articles in FDLI Update magazine and the Tobacco Reporter on FDA regulation of tobacco products and e-cigarettes
  • Advised concerning labeling of e-cigarettes in the European Union
  • Advised concerning permitted ingredients in tobacco products under National legislation in Europe and around the world
  • Advised concerning novel technologies for harm reduction in tobacco products
  • Advised concerning regulation of tobacco additives under the EU REACH Regulation
  • Advised concerning import and export of tobacco products under U.S. law